{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T10:40:42Z","timestamp":1752230442463,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 69-year-old woman presented with progressive dysarthria and cognitive deficits. On MRI, a T2-hyperintense, non\u2013contrast-enhancing lesion was found in the left precentral area. <jats:sup>18<\/jats:sup>F-FET and <jats:sup>18<\/jats:sup>F-FDG PET scans revealed faint amino acid uptake and glucose hypometabolism of the lesion. To assess a neuroinflammatory component, TSPO PET with <jats:sup>18<\/jats:sup>F-GE-180 was performed, where tracer uptake markedly exceeded the T2-hyperintense areas. Histology derived from a stereotactic biopsy findings confirmed John Cunningham virus\u2013associated progressive multifocal leukoencephalopathy. This case underlines that TSPO PET comprises distinct imaging advantages over other established radioligands such as <jats:sup>18<\/jats:sup>F-FET and <jats:sup>18<\/jats:sup>F-FDG in progressive multifocal leukoencephalopathy.<\/jats:p>","DOI":"10.1097\/rlu.0000000000004093","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T17:55:35Z","timestamp":1645638935000},"page":"543-544","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy"],"prefix":"10.1097","volume":"47","author":[{"given":"Marcus","family":"Unterrainer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Mahler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian-Minh","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Ruf","sequence":"additional","affiliation":[{"name":"Department of Neuropathology and Prion Research, LMU Munich, Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Blum","sequence":"additional","affiliation":[{"name":"Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Quach","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, University Hospital, LMU Munich, Munich"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Brendel","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[{"name":"Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bartenstein","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kerschensteiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tania","family":"K\u00fcmpfel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie L.","family":"Albert","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,2,21]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13139-017-0475-8","article-title":"Recent progress in the development of TSPO PET ligands for neuroinflammation imaging in neurological diseases","volume":"51","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1007\/s00259-018-3974-7","article-title":"TSPO PET with [18F] GE-180 sensitively detects focal neuroinflammation in patients with relapsing\u2013remitting multiple sclerosis","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13550-017-0340-x","article-title":"TSPO imaging using the novel PET ligand [18F]GE-180: quantification approaches in patients with multiple sclerosis","volume":"7","year":"2017","journal-title":"EJNMMI Res"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"9928","DOI":"10.1128\/JVI.00441-06","article-title":"JC virus evolution and its association with human populations","volume":"80","year":"2006","journal-title":"J Virol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","article-title":"PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids","volume":"72","year":"2009","journal-title":"Neurology"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","year":"2010","journal-title":"Lancet Neurol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S1474-4422(18)30040-1","article-title":"Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned","volume":"17","year":"2018","journal-title":"Lancet Neurol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/brain\/awab127","article-title":"TSPO PET of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"144","year":"2021","journal-title":"Brain"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004093","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:01:13Z","timestamp":1750536073000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,21]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004093","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,2,21]]}}}